Metamaterials Enabling Medical Breakthroughs, Promise Affordable, Accurate Point-of-Care Diagnostics — Part 1 | INN

Advertisement

BEGIN ARTICLE PREVIEW:

Part one of this series covers the long-term trend toward point-of-care technologies and companies involved in diabetes management.

Dr. McCoy’s medical tricorder from the iconic Star Trek series is an ideal which medical researchers and device developers continue to pursue: a non-invasive, point-of-care, diagnostic tool, able to see inside the human body and make an immediate diagnosis. However, a fundamental challenge is that the skin reflects electromagnetic waves and prevents incoming signals from entering the body.
Metamaterial Inc. (CSE:MMAT) has developed metamaterial films which cancel skin reflections, increasing the signal to noise ratio. The Company is developing several applications which integrate this technology, including pain-free, non-invasive blood glucose monitoring for diabetics; earlier breast cancer screening; higher quality, lower cost MRI imaging; and more rapid treatment of stroke.
This article is the first of a three part series. Part 1 covers the long-term trend toward point-of-care (POC) technologies and companies involved in diabetes management. Part 2 (still to come) examines medical imaging including mammography and MRI, and Part 3 (still to come) explores traumatic brain injury (TBI), concussion and stroke.

This INNspired Article is brought to you by:
Metamaterial Inc. (CSE:MMAT) specializes in the design and nanofabrication of highly functional materials …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE